Court agrees with Watson's interpretation of Lidoderm patent

06/28/2011 | Wall Street Journal, The

A U.S. District Court sided with Watson Pharmaceuticals in a patent dispute involving Endo Pharmaceuticals Holdings' painkilling patch Lidoderm. Watson is seeking regulatory approval to launch a generic Lidoderm. Endo "will explore a number of different legal options, one of which could be an appeal," said Blaine Davis, vice president of corporate affairs.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA